Glucagon-like peptide 2 inhibits ghrelin secretion in humans

Regulatory Peptides

Volumn 137, Issue 3, 2006, Pages 173-178

  Banasch, Matthias ^a   Bulut, Kerem ^a   Hagemann, Dirk ^a   Schrader, Henning ^a   Holst, Jens J ^b   Schmidt, Wolfgang E ^a   Meier, Juris J ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Ghrelin; GLP 2; Glucagon like peptide 2; Insulin

Indexed keywords

C PEPTIDE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; INSULIN; PLACEBO;

ADULT; ARTICLE; BLOOD LEVEL; DIET RESTRICTION; DRUG INFUSION; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE INHIBITION; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; STEADY STATE; VOLUNTEER;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 2; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; KINETICS; MALE; PEPTIDE HORMONES;

EID: 33751523539     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2006.07.009     Document Type: Article

References (48)

1. Kojima M., Hosoda H., Date Y., et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
2. Sakata I., Nakamura K., Yamazaki M., et al. Ghrelin-producing cells exist as two types of cells, closed-and opened-type cells, in the rat gastrointestinal tract. Peptides 23 (2002) 531-536
3. Date Y., Kojima M., Hosoda H., et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 141 (2000) 4255-4261
4. Tschop M., Smiley D.L., and Heiman M.L. Ghrelin induces adiposity in rodents. Nature 407 (2000) 908-913
5. Nakazato M., Murakami N., Date Y., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
6. Wren A.M., Small C.J., Ward H.L., et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141 (2000) 4325-4328
7. Asakawa A., Inui A., Kaga T., et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology 120 (2001) 337-345
8. Arvat E., Di Vito L., Broglio F., et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Investig 23 (2000) 493-495
9. Wren A.M., Seal L.J., Cohen M.A., et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86 (2001) 5992
10. Broglio F., Arvat E., Benso A., et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86 (2001) 5083-5086
11. Date Y., Nakazato M., Murakami N., et al. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun 280 (2001) 904-907
12. Cummings D.E., Purnell J.Q., Frayo R.S., et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50 (2001) 1714-1719
13. Cummings D.E., Weigle D.S., Frayo R.S., et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346 (2002) 1623-1630
14. Djurhuus C.B., Hansen T.K., Gravholt C., et al. Circulating levels of ghrelin and GLP-1 are inversely related during glucose ingestion. Horm Metab Res 34 (2002) 411-413
15. Djurhuus C.B., Hansen T.K., Holst J.J., and Schmitz O. Feast or famine - are GLP-1 and ghrelin secretion intertwined?. Horm Metab Res 34 (2002) 353-354
16. Lippl F., Kircher F., Erdmann J., Allescher H.D., and Schusdziarra V. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regul Pept 119 (2004) 93-98
17. Meneilly G.S., Greig N., Tildesley H., et al. Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care 26 (2003) 2835-2841
18. Rudovich N.N., Dick D., Moehlig M., et al. Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine. Regul Pept 127 (2005) 95-99
19. Bell G.I., Sanchez-Pescador R., Laybourn P.J., and Najarian R.C. Exon duplication and divergence in the human preproglucagon gene. Nature 304 (1983) 368-371
20. Bell G.I., Santerre R.F., and Mullenbach G.T. Hamster preproglucagon gene contains the sequence of glucagon and two related peptides. Nature 302 (1983) 716-718
21. Ørskov C., Holst J.J., Seier-Poulsen S., and Kirkegaard P. Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30 (1987) 874-881
22. Nauck M.A., Kleine N., Ørskov C., et al. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36 (1993) 741-744
23. Meier J.J., and Nauck M.A. Glucagon-like peptide 1 (GLP-1) in biology and pathology. Diabetes Metab Res Rev 21 (2005) 91-117
24. Ørskov C., Holst J.J., and Nielsen O.V. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 123 (1988) 2009-2013
25. Wettergren A., Schjoldager B., Mortensen P.E., et al. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38 (1993) 665-673
26. Meier J.J., Gallwitz B., Salmen S., et al. Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88 (2003) 2719-2725
27. Meier J.J., Nauck M.A., Pott A., et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 130 (2006) 44-54
28. Drucker D.J. Glucagon-like peptide 2. J Clin Endocrinol Metab 86 (2001) 1759-1764
29. Drucker D.J., Ehrlich P., Asa S.L., and Brubaker P.L. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci U S A 93 (1996) 7911-7916
30. Burrin D.G., Stoll B., Jiang R., et al. GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis. Am J Physiol Gastrointest Liver Physiol 279 (2000) G1249-G1256
31. Jeppesen P.B., Hartmann B., Thulesen J., et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120 (2001) 806-815
32. Drucker D.J. Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17 (2003) 161-171
33. Meier J.J., Nauck M.A., Kask B., et al. Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls. World J Gastroenterol 12 (2006) 1874-1880
34. Flanagan D.E., Evans M.L., Monsod T.P., et al. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284 (2003) E313-E316
35. Saad M.F., Bernaba B., Hwu C.M., et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87 (2002) 3997-4000
36. Mohlig M., Spranger J., Otto B., et al. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Investig 25 (2002) RC36-RC38
37. Hansen L., Deacon C.F., Orskov C., and Holst J.J. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dideptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 140 (1999) 5356-5363
38. Hartmann B., Johnsen A.H., Orskov C., et al. Structure, measurement, and secretion of human glucagon-like peptide-2. Peptides 21 (2000) 73-80
39. Ljungmann K., Hartmann B., Kissmeyer-Nielsen P., et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am J Physiol Gastrointest Liver Physiol 281 (2001) G779-G785
40. Xiao Q., Boushey R.P., Cino M., Drucker D.J., and Brubaker P.L. Circulating levels of glucagon-like peptide-2 in human subjects with inflammatory bowel disease. Am J Physiol Regul Integr Comp Physiol 278 (2000) R1057-R1063
41. Jeppesen P.B., Hartmann B., Thulesen J., et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 47 (2000) 370-376
42. Sørensen L.B., Flint A., Raben A., et al. No effect of physiological concentrations of glucagon-like peptide-2 on appetite and energy intake in normal weight subjects. Int J Obes Relat Metab Disord 27 (2003) 450-456
43. Schmidt P.T., Naslund E., Gryback P., et al. Peripheral administration of GLP-2 to humans has no effect on gastric emptying or satiety. Regul Pept 116 (2003) 21-25
44. Tang-Christensen M., Larsen P.J., Thulesen J., Romer J., and Vrang N. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 6 (2000) 802-807
45. Lovshin J., Estall J., Yusta B., Brown T.J., and Drucker D.J. Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem 276 (2001) 21489-21499 [Electronic publication 2001 Mar 21]
46. Yusta B., Huang L., Munroe D., et al. Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119 (2000) 744-755
47. Arafat M.A., Otto B., Rochlitz H., et al. Glucagon inhibits ghrelin secretion in humans. Eur J Endocrinol 153 (2005) 397-402
48. Dornonville de la Cour C., Bjorkqvist M., Sandvik A.K., et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 99 (2001) 141-150